Orphazyme20.jpg

ADS FAQs

ADS FAQs

In March 2022, we voluntarily delisted ADSs representing our ordinary shares from the Nasdaq Global Select Market in the United States, which became effective March 31, 2022.

The Bank of New York Mellon served as depositary, or the Depositary, for our American Depositary Share, or ADS, facility. Each ADS represented one of our ordinary shares. The Depositary terminated the Deposit Agreement, dated September 28, 2020 among us, the Depositary, and owners and holders of ADSs on July 6, 2022.  

The Depositary has no current obligation to deliver ordinary shares underlying the ADSs to holders and, since July 11, 2022, has had the ability to sell such shares.

If the Depositary has sold such shares, holders of ADSs must surrender such securities in order to obtain payment of the sale proceeds of the underlying ordinary shares, net of the expenses of sale, any applicable U.S. or local taxes or government charges and a cancellation fee of up to $0.05 per ADS.

To surrender ADSs, the address of the Depositary is: The Bank of New York Mellon, 240 Greenwich Street, Depositary Receipts Division – 8th Floor, Attention: Cancellation Desk, New York, NY 10286. Registered or overnight mail is the suggested method of delivering ADSs to the Depositary. For Settlement specific inquiries, please contact DRsettlements@bnymellon.com.

For more information, investors should contact DRBrokerSolutions@bnymellon.com.